| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Molecular Biology, Cancer Research Institute
and2 Department of Obstetrics and Gynaecology, Sapporo Medical College, S1, W17, Chuo-ku, Sapporo 060
and3 Bio Research Laboratories, Takara Shuzo Co. Ltd, Seta 3-4-1, Otsu, Shiga 520-21, Japan
A simple method has been developed for detecting a broad range of genital human papillomavirus (HPV) types using the polymerase chain reaction (PCR). We utilized two consensus sequence primer pairs within the E6 and E7 open reading frames to amplify HPV DNA; malignant HPV DNA (from HPV-16, -18, -31, -33, -52b and -58) was amplified using the pU-1M/pU-2R primer pair whereas benign HPV DNA (from HPV-6 and -11) was amplified using the pU-31B/pU-2R primer pair. Identification of the amplification product was confirmed by restriction enzyme digestion. In this study, a pU-1M/pU-2R-mediated PCR was successfully applied to 39 cervical carcinoma specimens; HPV-16 was detected in 19 cases, HPV-18 in five cases, HPV-31 in two cases, HPV-33 in two cases, HPV-52b in one case, HPV-58 in three cases, and an unknown type(s) was detected in four cases. Overall, the prevalence of HPV was 84.6%. The results indicate that this detection system is useful for the detection of HPVs not only of known types but also of new types.
Received 30 November 1990;
accepted 22 January 1991.
This article has been cited by other articles:
|
|
 |
|
  M. E. Manjarrez, R. Ocadiz, L. Valle, C. Pacheco, A. Marroquin, C. De la Torre, M. Selman, and P. Gariglio Detection of Human Papillomavirus and Relevant Tumor Suppressors and Oncoproteins in Laryngeal Tumors Clin. Cancer Res., December 1, 2006; 12(23): 6946 - 6951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Gheit, S. Landi, F. Gemignani, P. J. F. Snijders, S. Vaccarella, S. Franceschi, F. Canzian, and M. Tommasino Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J. Clin. Microbiol., June 1, 2006; 44(6): 2025 - 2031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Takubo, N. Shimomura-Izumiyama, H. Koiwai, N. Honma, Y. Esaki, T. Yoshida, T. Nakajima, M. Sawabe, and T. Arai Detection of Human Papillomavirus Infection of the Cervix in Very Elderly Women Using PCR Clin. Cancer Res., April 15, 2005; 11(8): 2919 - 2923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Lukaszuk, J Liss, I Wozniak, W Sliwinski, J Emerich, and C Wojcikowski HPV and histological status of pelvic lymph node metastases in cervical cancer: a prospective study J. Clin. Pathol., May 1, 2004; 57(5): 472 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Li, D. S. Gerhard, Z. Zhang, P. C. Huettner, J. Wright, L. Nguyen, D. Lu, and J. S. Rader Denaturing High-Performance Liquid Chromatography for Detecting and Typing Genital Human Papillomavirus J. Clin. Microbiol., December 1, 2003; 41(12): 5563 - 5571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Banuelos, E. Reyes, R. Ocadiz, E. Alvarez, M. Moreno, A. Monroy, and P. Gariglio Neocarzinostatin Induces an Effective p53-Dependent Response in Human Papillomavirus-Positive Cervical Cancer Cells J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 671 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W Grayson, L F Taylor, U Allard, A J Tiltman, and H A Rhemtula Detection of human papillomavirus in large cell neuroendocrine carcinoma of the uterine cervix: a study of 12 cases J. Clin. Pathol., February 1, 2002; 55(2): 108 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. NEUMAN, P. C. HUETTNER, L. LI, E. R. MARDIS, B. F. DUFFY, R. K. WILSON, and J. S. RADER Association Between DQB1 and Cervical Cancer in Patients With Human Papillomavirus and Family Controls Obstet. Gynecol., January 1, 2000; 95(1): 134 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yamashita, Y. Yaginuma, Y. Saitoh, K. Kawai, T. Kurakane, H. Hayashi, and M. Ishikawa Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix Carcinogenesis, September 1, 1999; 20(9): 1733 - 1736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Santin, P. L. Hermonat, A. Ravaggi, M. Chiriva-Internati, D. Zhan, S. Pecorelli, G. P. Parham, and M. J. Cannon Induction of Human Papillomavirus-Specific CD4+ and CD8+ Lymphocytes by E7-Pulsed Autologous Dendritic Cells in Patients with Human Papillomavirus Type 16- and 18-Positive Cervical Cancer J. Virol., July 1, 1999; 73(7): 5402 - 5410. [Abstract] [Full Text]
|
|
|
|
|
|
A. D. SANTIN, P. L. HERMONAT, A. RAVAGGI, S. PECORELLI, M. J. CANNON, and G. P. PARHAM Secretion of Vascular Endothelial Growth Factor in Adenocarcinoma and Squamous Cell Carcinoma of the Uterine Cervix Obstet. Gynecol., July 1, 1999; 94(1): 78 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Nakamura, Y. Mashima, K. Kameyama, M. Mukai, and Y. Oguchi Detection of human papillomavirus infection in squamous tumours of the conjunctiva and lacrimal sac by immunohistochemistry, in situ hybridisation, and polymerase chain reaction Br. J. Ophthalmol., April 1, 1997; 81(4): 308 - 313. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
